LDHA and nonpapillary renal cell carcinoma: ccRCC, characterized by high glucose uptake and enhanced levels/activities of glycolytic enzymes, such as hexokinase and LDHA, has been aptly labeled as a metabolic disease (Wettersten et al., 2017).